SOUND Pesticide Research Act

119 HR 10145 IH: Scientific Oversight for Unbiased and Neutral Data in Pesticide Research Act U.S. House of Representatives 2026-08-24 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I119th CONGRESS2d SessionH. R. 10145IN THE HOUSE OF REPRESENTATIVESAugust 24, 2026Ms. Mace introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend the Federal Food, Drug, and Cosmetic Act to direct the Administrator of the Environmental Protection Agency to rely on certain data with respect to a toxicity determination related to a pesticide chemical residue, and for other purposes.1.Short titleThis Act may be cited as the Scientific Oversight for Unbiased and Neutral Data in Pesticide Research Act or the SOUND Pesticide Research Act.2.Multigenerational reproductive toxicity study requirement(a)In generalSection 408(b)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 346a(b)(2)) is amended by adding at the end the following:(G)Multigenerational reproductive toxicity study(i)RequirementsIn establishing, modifying, leaving in effect, or revoking a tolerance or exemption for a pesticide chemical residue, the Administrator shall rely on data that is—(I)comprehensive, as determined by the Administrator; and(II)derived from a multigenerational reproductive toxicity study that includes not fewer than 4 generations of test species.(ii)ReviewNot later than 180 days after the date of enactment of the Scientific Oversight for Unbiased and Neutral Data Research Act of 2026, the Administrator shall determine whether each determination to establish, modify, revoke, or leave in effect a tolerance or exemption for a pesticide chemical residue under this section is supported by data that meets the requirements under clause (i)..(b)ReportNot later than 2 years after the date of enactment of this Act, the Administrator of the Environmental Protection Agency shall submit to Congress a report that identifies each determination that was reviewed, updated, or otherwise changed as a result of the amendments made to section 408(b)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 346a(b)(2)) by this section.